SCHEMBL14304598

SCHEMBL14304598

CCc1nc2ccccc2c(=O)n1-c1ccccc1COC

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.70
ALDH1A1 P00352 6/20 0.60
KMT2A Q03164 2/20 0.49
CYP1A2 P05177 2/20 0.48
CYP3A4 P08684 2/20 0.48
CYP2C9 P11712 2/20 0.48
CYP2C19 P33261 2/20 0.48
MEN1 O00255 1/20 0.48
CYP2D6 P10635 1/20 0.48
LMNA P02545 3/20 0.48
PDE10A Q9Y233 1/20 0.47
HIF1A Q16665 2/20 0.47
MAPT P10636 2/20 0.47
GAA P10253 1/20 0.47
KDM4E B2RXH2 1/20 0.47
HPGD P15428 1/20 0.47
USP2 O75604 1/20 0.46
TSHR P16473 1/20 0.46
MAPK1 P28482 1/20 0.46
KCNH2 Q12809 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14305182 0.86 L3MBTL1 (0.67) L3MBTL1ALDH1A1KMT2ACYP1A2CYP3A4
SCHEMBL11435540 0.81 L3MBTL1 (0.71) L3MBTL1ALDH1A1KMT2AMEN1LMNA
Etaqualone SCHEMBL30726094 0.80 ALDH1A1 (0.73) L3MBTL1ALDH1A1KMT2ALMNAMAPT
Etaqualone SCHEMBL29357362 0.80 ALDH1A1 (0.73) L3MBTL1ALDH1A1KMT2ALMNAMAPT
Etaqualone SCHEMBL466318 0.80 ALDH1A1 (0.73) L3MBTL1ALDH1A1KMT2ALMNAMAPT
Etaqualone SCHEMBL30726099 0.80 ALDH1A1 (0.73) L3MBTL1ALDH1A1KMT2ALMNAMAPT
SCHEMBL14447224 0.80 L3MBTL1 (0.45) L3MBTL1ALDH1A1KMT2ACYP1A2CYP2C9
SCHEMBL4465299 0.79 L3MBTL1 (0.79) L3MBTL1ALDH1A1LMNAHIF1ATSHR
SCHEMBL8242227 0.77 NPC1 (0.70) L3MBTL1ALDH1A1KMT2ACYP1A2CYP3A4
SCHEMBL1129120 0.76 ALDH1A1 (0.54) L3MBTL1ALDH1A1KMT2ACYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008013840-A2 ERASTIN ANALOGS AND USES THEREOF TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) 2008-01-31 WO disclosed
US-20070161644-A1 Erastin analogs and uses thereof STOCKWELL BRENT R 2007-07-12 US disclosed
US-20070161644-A1 Erastin analogs and uses thereof STOCKWELL BRENT R 2007-07-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070161644-A1 Erastin analogs and uses thereof ERAP2, ERAP1, ERAL1 L3MBTL1 4245/4885ALDH1A1 1049/4885KMT2A 3738/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.